To better serve the increasing market demand for enantio- and diastereomerically pure chiral building blocks, DSM has created a portfolio of technologies aimed at generating '100% yield and 100% e.e.' concepts for producing chiral molecules. These challenges are being tackled in an integrated manner, whereby a combination of proprietary technologies is increasingly being used alongside the single competences (biocatalysis, homogeneous catalysis and oxidation) and diastereomeric resolution.